Literature DB >> 10228765

Technical aspects and clinical indications of 24-hour intragastric bile monitoring.

P Bechi1, F Cianchi.   

Abstract

Bilitec 2000 is a new device which spectrophotometrically detects the presence of bilirubin in the refluxate. It is, up to date, the only method able to monitor for 24 hours the exposure time of esophageal and/or gastric mucosa to bilirubin-containing reflux. From the technical point of view, a particularly relevant aspect is the necessity of associating pH and Bilitec monitorings. The reason why is that, even in the stomach where Bilitec itself is adequate for assessing the exposure time to duodenogastric reflux, the damaging capability of the different components of reflux strictly depends upon pH. The most correct position inside the stomach for gastric monitoring is the 5 cm-below-the-LES-distal-border-position. The diet needs to be standardized in order to avoid false positive results due to the ingestion of foods with absorption close to bilirubin absorption. Ranges of normality will soon be available from a collaborative European Study. At variance with the indications for esophageal monitoring which are wide (the same as for pH-monitoring), indications for gastric Bilitec monitoring are represented only by severe dyspeptic symptoms possibly related to duodenogastric reflux. An antrum-confined C gastritis in the absence of history of consumption of gastro-lesive drugs strongly suggests the possibility of duodenogastric reflux. In this case, Bilitec monitoring can provide further evidence by measuring the time of exposure of the gastric mucosa to reflux.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10228765

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  3 in total

1.  Assessment of duodenogastric reflux by combined continuous intragastric pH and bilirubin monitoring.

Authors:  Fei Dai; Jun Gong; Ru Zhang; Jin-Yan Luo; You-Ling Zhu; Xue-Qin Wang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

2.  Duodeno-jejunal junction dyssynergia: description of a novel syndrome.

Authors:  Ahmed Shafik; Ismail A Shafik; Olfat El Sibai; Ali A Shafik
Journal:  World J Gastroenterol       Date:  2007-08-14       Impact factor: 5.742

3.  Bile reflux index after therapeutic biliary procedures.

Authors:  Sedef Kuran; Erkan Parlak; Gulden Aydog; Sabite Kacar; Nurgul Sasmaz; Ali Ozden; Burhan Sahin
Journal:  BMC Gastroenterol       Date:  2008-02-11       Impact factor: 3.067

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.